Epinephrine: A new pharmacologic treatment for no-reflow?

Catheterization and Cardiovascular Interventions

Volumn 57, Issue 3, 2002, Pages 310-311

  Baim, Donald S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADRENALIN; CREATINE KINASE; CREATINE KINASE MB; DILTIAZEM; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; NICARDIPINE; NITROPRUSSIDE SODIUM; VERAPAMIL;

CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; GUIDE WIRE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; HYPOTENSION; NOTE; SAPHENOUS VEIN GRAFT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD FLOW VELOCITY; CORONARY CIRCULATION; CORONARY DISEASE; EPINEPHRINE; HOSPITAL MORTALITY; HUMANS; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 0036842195     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10320     Document Type: Note

References (7)

1. Hong MK, Mehran R, Dangas G, et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 1999;100:2400.
2. Pomerantz RM, Kuntz RE, Diver DJ, Safian RD, Baim DS. Intracoronary verapamil for the treatment of distal microvascular coronary artery spasm following PTCA. Cathet Cardiovasc Diagn 1991;24:283-285.
3. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, Carrozza JP Jr, Kuntz RE, Baim DS. Incidence and treatment of "no-reflow" after percutaneous coronary intervention. Circulation 1994:89:2514-2518.
4. Baim DS, Carrozza JP Jr. Understanding the "no-reflow" problem. Cathet Cardiovasc Diagn 1996;39:7-8.
5. Skelding KA, Goldstein JA, Mehta L, Pica MC, O'Neill WW. Resolution of refractory no-reflow with intracoronary epinephrine. Cathet Cardiovasc Intervent 2002;57:305-309.
6. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KKL, Kuntz RE, on behalf of the Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) trial investigators. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aortocoronary bypass grafts. Circulation 2002;105:13-18.
7. Ellis SG, Linkoff AM, Miller D, et al. Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. J Am Coll Cardiol 1998;32:1619-1623.